Binding Site Information of Target
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T52382 | Target Info | |||
Target Name | Lymphocyte antigen 96 (LY96) | ||||
Synonyms | MD-2 protein; MD-2; LY96; ESOP-1 | ||||
Target Type | Literature-reported Target | ||||
Gene Name | LY96 | ||||
UniProt ID |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: ERITORAN | Ligand Info | |||||
Structure Description | Crystal structure of the human TLR4 TV3 hybrid-MD-2-Eritoran complex | PDB:2Z65 | ||||
Method | X-ray diffraction | Resolution | 2.70 Å | Mutation | No | [1] |
PDB Sequence |
QKQYWVCNSS
28 DASISYTYCD38 KMQYPISINV48 NPCIELKGSK58 GLLHIFYIPR68 RDLKQLYFNL 78 YITVNTMNLP88 KRKEVICRGS98 DDDYSFCRAL108 KGETVNTTIS118 FSFKGIKFSK 128 GKYKCVVEAI138 SGSPEEMLFC148 LEFVILHQPN158
|
|||||
|
ILE32
4.452
ILE46
3.506
VAL48
4.481
ILE52
4.217
LEU54
4.852
LEU61
3.964
ILE63
3.727
TYR65
3.497
LEU71
4.181
LEU74
4.596
PHE76
3.934
LEU78
4.528
ILE80
4.211
LEU87
3.649
ILE94
4.934
TYR102
3.372
PHE104
3.522
|
|||||
Ligand Name: Myristic acid | Ligand Info | |||||
Structure Description | Crystal structure of human MD-2 | PDB:2E56 | ||||
Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | No | [2] |
PDB Sequence |
EAQKQYWVCN
26 SSDASISYTY36 CDKMQYPISI46 NVNPCIELKG56 SKGLLHIFYI66 PRRDLKQLYF 76 NLYITVNTMN86 LPKRKEVICR96 GSDDDYSFCR106 ALKGETVNTT116 ISFSFKGIKF 126 SKGKYKCVVE136 AISGSPEEML146 FCLEFVILHQ156 PNSN
|
|||||
|
ILE32
4.276
ILE44
4.638
ILE46
4.340
VAL48
3.569
ILE52
3.151
LEU61
3.752
ILE63
4.142
TYR65
4.270
LEU71
4.406
LEU74
4.064
PHE76
4.051
LEU78
4.272
GLU92
3.930
VAL93
4.556
ILE94
4.019
|
|||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: Lauric acid | Ligand Info | |||||
Structure Description | Crystal structure of human TLR4 polymorphic variant D299G and T399I in complex with MD-2 and LPS | PDB:4G8A | ||||
Method | X-ray diffraction | Resolution | 2.40 Å | Mutation | Yes | [3] |
PDB Sequence |
QKQYWVCNSS
28 DASISYTYCD38 KMQYPISINV48 NPCIELKGSK58 GLLHIFYIPR68 RDLKQLYFNL 78 YITVNTMNLP88 KRKEVICRGS98 DDDYSFCRAL108 KGETVNTTIS118 FSFKGIKFSK 128 GKYKCVVEAI138 SGSPEEMLFC148 LEFVILHQPN158
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .DAO or .DAO2 or .DAO3 or :3DAO;style chemicals stick;color identity;select .C:54 or .C:78 or .C:80 or .C:90 or .C:92 or .C:126 or .C:131 or .C:133 or .C:153; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: 2-Deoxy-3-O-[(3r)-3-Hydroxytetradecanoyl]-2-{[(3r)-3-Hydroxytetradecanoyl]amino}-4-O-Phosphono-Beta-D-Glucopyranose | Ligand Info | |||||
Structure Description | Crystal structure of human MD-2 in complex with lipid IVa | PDB:2E59 | ||||
Method | X-ray diffraction | Resolution | 2.21 Å | Mutation | No | [2] |
PDB Sequence |
EAQKQYWVCN
26 SSDASISYTY36 CDKMQYPISI46 NVNPCIELKG56 SKGLLHIFYI66 PRRDLKQLYF 76 NLYITVNTMN86 LPKRKEVICR96 GSDDDYSFCR106 ALKGETVNTT116 ISFSFKGIKF 126 SKGKYKCVVE136 AISGSPEEML146 FCLEFVILHQ156 PNSN
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .LP4 or .LP42 or .LP43 or :3LP4;style chemicals stick;color identity;select .A:32 or .A:48 or .A:52 or .A:54 or .A:61 or .A:78 or .A:80 or .A:90 or .A:119 or .A:120 or .A:121 or .A:122 or .A:123 or .A:124 or .A:131 or .A:132 or .A:133 or .A:151 or .A:153; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: lipid X | Ligand Info | |||||
Structure Description | Crystal structure of human MD-2 in complex with lipid IVa | PDB:2E59 | ||||
Method | X-ray diffraction | Resolution | 2.21 Å | Mutation | No | [2] |
PDB Sequence |
EAQKQYWVCN
26 SSDASISYTY36 CDKMQYPISI46 NVNPCIELKG56 SKGLLHIFYI66 PRRDLKQLYF 76 NLYITVNTMN86 LPKRKEVICR96 GSDDDYSFCR106 ALKGETVNTT116 ISFSFKGIKF 126 SKGKYKCVVE136 AISGSPEEML146 FCLEFVILHQ156 PNSN
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .LP5 or .LP52 or .LP53 or :3LP5;style chemicals stick;color identity;select .A:44 or .A:46 or .A:61 or .A:63 or .A:65 or .A:71 or .A:74 or .A:76 or .A:78 or .A:92 or .A:94 or .A:102 or .A:104 or .A:117 or .A:118 or .A:119 or .A:120 or .A:122 or .A:133 or .A:135 or .A:146 or .A:147 or .A:149 or .A:151; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ILE44
4.611
ILE46
3.839
LEU61
3.855
ILE63
3.703
TYR65
3.979
LEU71
4.204
LEU74
3.522
PHE76
3.696
LEU78
3.998
GLU92
3.733
ILE94
4.103
TYR102
3.895
|
|||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: 3-Hydroxytetradecanoic acid | Ligand Info | |||||
Structure Description | Crystal structure of the human TLR4-human MD-2-E.coli LPS Ra complex | PDB:3FXI | ||||
Method | X-ray diffraction | Resolution | 3.10 Å | Mutation | No | [4] |
PDB Sequence |
QKQYWVCNSS
28 DASISYTYCD38 KMQYPISINV48 NPCIELKGSK58 GLLHIFYIPR68 RDLKQLYFNL 78 YITVNTMNLP88 KRKEVICRGS98 DDDYSFCRAL108 KGETVNTTIS118 FSFKGIKFSK 128 GKYKCVVEAI138 SGSPEEMLFC148 LEFVILHQPN158
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FTT or .FTT2 or .FTT3 or :3FTT;style chemicals stick;color identity;select .C:24 or .C:32 or .C:46 or .C:48 or .C:52 or .C:54 or .C:61 or .C:63 or .C:65 or .C:71 or .C:74 or .C:76 or .C:80 or .C:82 or .C:87 or .C:90 or .C:94 or .C:102 or .C:104 or .C:117 or .C:118 or .C:119 or .C:120 or .C:121 or .C:122 or .C:123 or .C:124 or .C:125 or .C:126 or .C:127 or .C:131 or .C:133 or .C:135 or .C:146 or .C:147 or .C:151 or .C:153; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
VAL24
3.712
ILE32
3.890
ILE46
4.044
VAL48
3.789
ILE52
4.166
LEU54
4.973
LEU61
3.914
ILE63
3.802
TYR65
3.556
LEU71
3.453
LEU74
3.844
PHE76
3.829
ILE80
4.626
VAL82
3.622
LEU87
3.681
ARG90
3.975
ILE94
4.411
TYR102
3.920
PHE104
3.633
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell. 2007 Sep 7;130(5):906-17. | ||||
REF 2 | Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science. 2007 Jun 15;316(5831):1632-4. | ||||
REF 3 | Structural analyses of human Toll-like receptor 4 polymorphisms D299G and T399I. J Biol Chem. 2012 Nov 23;287(48):40611-7. | ||||
REF 4 | The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature. 2009 Apr 30;458(7242):1191-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.